These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 37061693
41. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. Gorman E, Shankar-Hari M, Hopkins P, Tunnicliffe WS, Perkins GD, Silversides J, McGuigan P, Jackson C, Boyle R, McFerran J, McDowell C, Campbell C, McFarland M, Smythe J, Thompson J, Williams B, Curley G, Laffey JG, Clarke M, O'Kane C, McAuley DF. Trials; 2020 Jun 03; 21(1):462. PubMed ID: 32493473 [Abstract] [Full Text] [Related]
42. Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial. Kanjo A, Molnar Z, Zádori N, Gede N, Erőss B, Szakó L, Kiss T, Márton Z, Malbrain MLNG, Szuldrzynski K, Szrama J, Kusza K, Kogelmann K, Hegyi P. BMJ Open; 2021 Aug 26; 11(8):e050464. PubMed ID: 34446497 [Abstract] [Full Text] [Related]
43. Sepsis Care Pathway 2019. Labib A. Qatar Med J; 2019 Aug 26; 2019(2):4. PubMed ID: 31763206 [Abstract] [Full Text] [Related]
44. Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children. Aygün F, Varol F, Durak C, Talip Petmezci M, Kacar A, Dursun H, Irdem A, Çokuğraş H, Camcıoğlu Y, Çam H. Medicina (Kaunas); 2019 Jul 07; 55(7):. PubMed ID: 31284692 [Abstract] [Full Text] [Related]
45. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Bruining HA, Otto C, Tobin E, Zwingelstein C, Lesslauer W, Leighton A. JAMA; 1997 May 21; 277(19):1531-8. PubMed ID: 9153367 [Abstract] [Full Text] [Related]
46. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Busund R, Koukline V, Utrobin U, Nedashkovsky E. Intensive Care Med; 2002 Oct 21; 28(10):1434-9. PubMed ID: 12373468 [Abstract] [Full Text] [Related]
47. Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)-study protocol for a randomized, controlled, interventional, open-label, multicenter trial. Brenner T, Skarabis A, Stevens P, Axnick J, Haug P, Grumaz S, Bruckner T, Luntz S, Witzke O, Pletz MW, Ruprecht TM, Marschall U, Altin S, Greiner W, Berger MM, TIFOnet Critical Care Trials Group. Trials; 2021 Oct 18; 22(1):714. PubMed ID: 34663439 [Abstract] [Full Text] [Related]
48. PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial. Weiss SL, Balamuth F, Long E, Thompson GC, Hayes KL, Katcoff H, Cook M, Tsemberis E, Hickey CP, Williams A, Williamson-Urquhart S, Borland ML, Dalziel SR, Gelbart B, Freedman SB, Babl FE, Huang J, Kuppermann N, Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PRoMPT BOLUS) Investigators of the PECARN, PERC, and PREDICT Networks. Trials; 2021 Nov 06; 22(1):776. PubMed ID: 34742327 [Abstract] [Full Text] [Related]
49. Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial. Unger M, Morelli A, Singer M, Radermacher P, Rehberg S, Trimmel H, Joannidis M, Heinz G, Cerny V, Dostál P, Siebers C, Guarracino F, Pratesi F, Biancofiore G, Girardis M, Kadlecova P, Bouvet O, Zörer M, Grohmann-Izay B, Krejcy K, Klade C, Krumpl G. Trials; 2018 Nov 19; 19(1):637. PubMed ID: 30454042 [Abstract] [Full Text] [Related]
50. Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction: a systematic review and meta-analysis. Kuklin V, Sovershaev M, Bjerner J, Keith P, Scott LK, Thomas OMT, Szpirt W, Rock G, Stegmayr B. Crit Care; 2024 Jan 04; 28(1):12. PubMed ID: 38178170 [Abstract] [Full Text] [Related]
59. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M. JAMA; 2013 Oct 23; 310(16):1683-91. PubMed ID: 24108526 [Abstract] [Full Text] [Related]
60. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ, VANISH Investigators. JAMA; 2016 Aug 02; 316(5):509-18. PubMed ID: 27483065 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]